Literature DB >> 6600980

In vivo localization of cloned IL-2-dependent T cells.

A M Carroll, M A Palladino, H Oettgen, M De Sousa.   

Abstract

The quantitative organ distribution and tissue microenvironment positioning of radioisotopically labeled cloned T cells were characterized. Intravenous (iv) injection of 51chromium (51Cr)-labeled, long-term cultured cloned T-helper cells and cells from several cloned cytolytic T-lymphocyte lines (CTLL) resulted in poor localization of these cells in recipient lymphoid tissues, similar to results reported for activated lymphoblastoid cells. Simultaneous administration of interleukin 2 (IL-2) with labeled cells resulted in enhanced recovery from recipient spleen. By the intraperitoneal (ip) injection route, overall percentage recovery of injected radioactivity was lower than by the iv route, but significant localization to lymph nodes occurred. Examination of autoradiographs of tissue sections from recipients of [3H]adenosine-labeled cells showed most label associated with intact, isolated cells in the liver, lungs, spleen, and small intestine. By 24 hr after iv injection, labeled cells in spleen sections were distributed to both nonlymphoid and T- and B-lymphoid areas. These findings suggest that poor localization of these cells to recipient lymphoid tissue is due both to intrinsic characteristics of cultured lymphocytes and to the possible reduced viability of IL-2-dependent cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6600980     DOI: 10.1016/0008-8749(83)90349-0

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  10 in total

1.  Recognition of thyroglobulin autoantigenic epitopes by murine T and B cells.

Authors:  B R Champion; K Page; D C Rayner; R Quartey-Papafio; P G Byfield; G Henderson
Journal:  Immunology       Date:  1987-10       Impact factor: 7.397

2.  Antigen-specific T-cell lines transfer protective immunity against Trichinella spiralis in vivo.

Authors:  J Riedlinger; R K Grencis; D Wakelin
Journal:  Immunology       Date:  1986-05       Impact factor: 7.397

3.  Influence of the donors' clinical status on in vitro and in vivo tumor-cytotoxic activation of interleukin-2-exposed lymphocytes and their circulation in different organs.

Authors:  M Rodolfo; C Salvi; G Parmiani
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Porins and lipopolysaccharide (LPS) from Salmonella typhimurium induce leucocyte transmigration through human endothelial cells in vitro.

Authors:  M Galdiero; A Folgore; M Molitierno; R Greco
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

5.  Antitumour efficacy of lymphokine-activated killer cells loaded with ricin against experimentally induced lung metastases.

Authors:  P Zanovello; A Rosato; V Bronte; S Mandruzzato; V Cerundolo; D Collavo
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

6.  Limiting-dilution analysis of T cells extracted from solid human lung tissue: comparison of precursor frequencies for proliferative responses and lymphokine production between lung and blood T cells from individual donors.

Authors:  P G Holt; U R Kees; M A Shon-Hegrad; A Rose; J Ford; N Bilyk; R Bowman; B W Robinson
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

7.  Lyt phenotype, lymphocyte migration and the selective tissue positioning of mouse T cell sets.

Authors:  A M Carroll; M de Sousa
Journal:  Immunology       Date:  1984-06       Impact factor: 7.397

8.  Transfer of murine host protection by using interleukin-2-dependent T-lymphocyte lines.

Authors:  C C Paul; K Norris; R Warren; R A Smith
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

9.  Antigen-driven long term-cultured T cells proliferate in vivo, distribute widely, mediate specific tumor therapy, and persist long-term as functional memory T cells.

Authors:  M A Cheever; D B Thompson; J P Klarnet; P D Greenberg
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

10.  Temporary inhibition of Moloney-murine sarcoma virus (M-MSV) induced-tumours by adoptive transfer of ricin-treated T-lymphocytes.

Authors:  V Cerundolo; P Zanovello; D McIntosh; R Fabbris; A J Davies; D Collavo
Journal:  Br J Cancer       Date:  1987-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.